Filing Flows › Charles River Laboratories International (CRL) › Free cash flow
Charles River Laboratories International (CRL) free cash flow by quarter
Charles River Laboratories International's free cash flow was $207M in Q3 2026 (third quarter 2026), +39% from Q2 2026. Over the last 6 quarters it ranged from $58.6M (Q4 2025) to $207M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $207M | +39% | +16% |
| Q2 2026 | $149M | +154% | -12% |
| Q4 2025 | $58.6M | -67% | — |
| Q3 2025 | $178M | +5% | — |
| Q2 2025 | $169M | +51% | — |
| Q1 2025 | $112M | — | — |
Q3 2026 at a glance
Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.
Questions
What is Charles River Laboratories International's free cash flow?
Charles River Laboratories International's free cash flow was $207M in Q3 2026 (third quarter 2026), +39% from Q2 2026.
How has Charles River Laboratories International's free cash flow changed?
Over the last 6 quarters it ranged from $58.6M (Q4 2025) to $207M (Q3 2026).
Q3 2026 results → · How Charles River Laboratories International makes money →